Resistance to apoptosis correlates with a highly proliferative phenotype and loss of FAS and CPP32 (caspase-3) expression in human leukemia cells

International Journal of Cancer

Volumn 75, Issue 3, 1998, Pages 473-481

  Martinez Lorenzo, María J ^a   Gamen, Susana ^a   Etxeberria, Jaime ^a   Lasierra, Pilar ^b   Larrad, Luis ^b   Piñeiro, Andrés ^a   Anel, Alberto ^a   Naval, Javier ^a   Alava, María A ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, CD95; APOPTOSIS; CELL DIVISION; CYSTEINE ENDOPEPTIDASES; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; LEUKEMIA, PROMYELOCYTIC, ACUTE; PHENOTYPE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED;

EID: 0032579226     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980130)75:3<473::AID-IJC23>3.0.CO;2-8     Document Type: Article

References (36)

1. ALLEY, M.C., SCUDIERO, D.A., MONKS, A., HURSEY, M.L., CZERWINSKI, M.J., FINE, D., ABBOT, B.J., MAYO, J.G., SHOEMAKER, R.H. and BOYD, M.R., Sensibility of drug screening with panels of human tumor cell lines using microculture tetrazolium assay. Cancer Res., 46, 589-601 (1988).
2. ANEL, A., GAMEN, S., ALAVA, M.A., SCHMITT-VERHULST, A.M., PIÑEIRO, A. and NAVAL, J., Role of oxidative damage and ICE-like proteases in Fas-based cytotoxicity exerted by effector T cells. Int. Immunol., 8, 1173-1183 (1996).
3. BEUTLER, B. and VAN HUFFEL, C., The TNF receptor superfamily. Science, 264, 667-668 (1994).
4. BOSE, R., VERHEIJ, M., HAIMOVITZ-FRIEDMAN, A., SCOTTO, K., FUKS, Z. and KOLESNICK, R., Ceramide synthase mediates daunorubicin-induced apopto- sis: an alternative mechanism for generating death signals. Cell. 82, 405-114 (1995).
5. BUFERNE, M., LUTON, F., LETOURNEUR, F., HOEVELER, A., COUEZ, D., BARAD, M., MALISSEN, B., SCHMITT-VERHULST, A.M. and BOYER, C., Role of CD3δ in surface expression of the TCR/CD3 complex and in activation for killing analyzed with a CD3δ-negative cytotoxic-T-lymphocyte variant. J. Immunol., 148, 657-664 (1992).
6. CHINNAIYAN, A.M., O'ROURKE, K., TEWARI, M. and DIXIT, V.M., FADD, a novel death-domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81, 505-512 (1995).
7. DECKERT, M., TICCHIONI, M., MARI, B., MARY, D. and BERNARD, A., The glycosylphosphatidylinositol-anchored CD59 protein stimulates both T-cell receptor/ZAP-70-dependent and -independent signaling pathways in T cells. Europ. J. Immunol., 25, 1815-1822 (1995).
8. DHEIN, J., WALCZAK, H., BÄUMLER, C., DEBATIN, K.M. and KRAMMER, P.H., Autocrine-T-cell suicide mediated by APO-1 (Fas/CD95). Nature (Lond.), 373, 438-441 (1995).
9. FRIESEN, C., HERR, I., KRAMMER, P.H. and DEBATIN, K.M., Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced upoptosis of leukemia cells. Nature Med., 2, 574-577 (1996).
10. GAMEN, S., MARZO, I., ANEL, A., PIÑEIRO, A. and NAVAL, J., CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS. Lett., 390, 233-237 (1996).
11. GAMEN, S., ANEL, A., PIÑEIRO, A. and NAVAL, J., Caspases, but not ceramide, are the main executioners of Fas-mediated apoptosis. Cell Death and Differentiation, (1997a).
12. GAMEN, S., ANEL, A., LASIERRA P., ALAVA, M.A., MARTÍNEZ-LORENZO, M.J., PIÑEIRO, A. and NAVAL J., Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independenl way. FEBS Lett. 417, 360-364 (1997b).
13. GUFFY, M., NORTH, J.A. and BURNS, C.P., Effect of cellular fatty-acid alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells. Cancer Res., 44, 1863-1866 (1984).
14. HENKART, P.A., ICE family proteases: mediators of all apoptotic cell death? Immunity, 4, 195-201 (1996).
15. JAFFRÉZOU, J.P., LEVADE, T., BETTAǏEB, A., ANDRIEU, N., BEZOMBES, C., MAESTRE, N., VERMEERSCH, S., ROUSSE, A. and LAURENT, G., Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J., 15, 2417-2424 (1996).
16. JUNG, Y.K., MIURA, M. and YUAN, J., Suppression of interleukin-1β-converting-enzyme-mediated cell death by insulin-like growth factor. J. biol. Chem., 271, 5112-5117 (1996).
17. KEANE, M.M., ETTENBERG, S.A., LOWREY, G.A., RUSSELL, E.K. and LIPKOWITZ, S., Fas expression and function in normal and malignant-breast-cancer cell lines. Cancer Res., 56, 4791-4798 (1996).
18. KUFFEL, M.J., REID, J.M. and AMES, M.M., Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture. Cancer Chemother. Pharmacol., 30, 51-57 (1992).
19. KUIDA, K., ZHENG, T.S., NA, S., KUAN, C.Y., YANG, D., KARASUYAMA, H., RAKIC, P. and FLAVELL, R.A., Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (Lond.), 384, 368-372 (1996).
20. MARTINEZ-LORENZO, M.J., ALAVA, M.A., ANEL, A., PIÑEIRO, A. and NAVAL, J., Release of preformed Fas ligand in its soluble form is the major factor for activation-induced death of Jurkat T lymphoblasts. Immunology 89, 511-517 (1996).
21. MASHIMA, T., NAITO, M., KATAOKA, S., KAWAI, H. and TSURUO, T., Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents anti-tumor-ugent-induced apoptosis in human myeloid leukemia U937 cells. Biochem. biophys. Res. Commun., 209, 907-915 (1995).
22. MOLLEREAU, B., DECKERT, M., DÉAS, O., RIEUX-LAUCAT, F., HIRSCH, F., BERNARD, A., FISCHER, A., LYNCH, D.H., CHARPENTIER, B., LE DEIST, F. and SENIK, A., CD2-induced apoptosis in activated human peripheral T cells. A Fas-independent pathway that requires early tyrosine phosphorylation. J. Immunol., 156, 3184-3190 (1996).
23. MUZIO, M. and 13 OTHERS, FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85, 817-827 (1996).
24. NAGATA, S. and GOLSTEIN, P., The Fas death factor. Science, 267, 1449-1456 (1995).
25. NICHOLSON, D.W. and 15 OTHERS, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376, 37-43 (1995).
26. PENG, S.L., ROBERT, M.E., HAYDAY, A.C. and CRAFT, J., A tumor-suppressor function for Fas (CD95) revealed in T-cell-deficient mice. J. exp. Med., 184, 1149-1154 (1996).
27. ROBERTSON, M.J., MANLEY, T.J., PIERCHERT, G., CAMERON, C., COCHARN, K.J., LEVINE, H. and RITZ, J., Functional co-sequences of APO-1/Fas(CD95)-antigen expression by normal and neoplastic hematopoietic cells. Leuk. Lymphoma. 17, 51-61 (1995).
28. 2+-independent T-cell-mediated cytotoxicity. J. exp. Med., 177, 195 (1993).
29. SINHA, B.K., KATKI, A.G., BATIST, G., COWAN, K.H. and MYERS, C.E., Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast-tumor cells: implications for the mechanism of action. Biochemistry, 26, 3776-3781 (1987).
30. SLEE, E.A., ZHU, H., CHOW, S.C., MACFARLANE, M., NICHOLSON, D.W. and COHEN, G.M., Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluorpmethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J., 315, 21-24 (1996).
31. SU, X., ZHOU, T., WANG, Z., YANG, P., JOPE, R.S. and MOUNTZ, J.D., Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity, 2, 353-362 (1995).
32. TAMURA, T., ISHIHARA, M., LAMPHIER, M.S., TANAKA, N., OISHI, T., AIZAWA, S., MATSUYAMA, T., MAK, T.W., TAKI, S. and TANIGUCHI, T., An IRF-1-dependent pathway of DNA-damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (Lond.), 376, 596-599 (1995).
33. TEWARI, M., QUAN, L.T., O'ROURKE, K., DESNOYERS, S., ZENG, Z., BEIDLER, D.R., POIRIER, G.G., SALVESEN, G.S. and DIXIT, V.M., Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81, 801-809 (1995).
34. THOMPSON, C.B., Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462 (1995).
35. TSUJIMOTO, Y., GORMAM, J., COSSMAN, J., JAFFE, E. and CROCE, C.M., The t(14; 18) chromosome translocations involved in B-cell neoplasm result from mistakes in VDJ joining. Science, 229, 1390-1393 (1985).
36. ZHENG, L., FISHER, G., MILLER, R.E., PESCHON, J., LYNCH, D.H. and LENARDO, M.J., Induction of apoptosis in mature T cells by tumor necrosis factor. Nature (Lond.), 377, 348-351 (1995).